The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agents-Reference-Cited by-同舟云学术

The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agents

Published:2009-05 Issue:9 Volume:19 Page:2537-2541
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

DeNinno Michael P.,Andrews Melissa,Bell Andrew S.,Chen Yue,Eller-Zarbo Cynthia,Eshelby Nan,Etienne John B.,Moore Dianna E.,Palmer Michael J.,Visser Michael S.,Yu Li J.,Zavadoski William J.,Michael Gibbs E.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference21 articles.

1. Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene ( PDE9A ) that maps to 21q22.3: alternative splicing of mRNA transcripts, genomic structure and sequence

2. Isolation and Characterization of PDE9A, a Novel Human cGMP-specific Phosphodiesterase

3. Chapter 1 Potential CNS Applications for Phosphodiesterase Enzyme Inhibitors

4. Design of Second Generation Phosphodiesterase 5 Inhibitors

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The therapeutic potential of phosphodiesterase 9 (PDE9) inhibitors: a patent review (2018-present);Expert Opinion on Therapeutic Patents;2024-07-09

2. A Review of Antidiabetic Medicinal Plants as a Novel Source of Phosphodiesterase Inhibitors: Future Perspective of New Challenges Against Diabetes Mellitus;Medicinal Chemistry;2024-06

3. Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy;Journal of Medicinal Chemistry;2023-07-20

4. Structural Optimization of BIPPO Analogs as Potent Antimalarials;Molecules;2023-06-23

5. Bicyclic 5–6 Systems: Other Four Heteroatoms 2:2;Comprehensive Heterocyclic Chemistry IV;2022